Chronic Care: Medicines, Devices & Coverage

Own the businesses that supply and finance ongoing treatment: chronic-disease medicines, implanted devices, monitoring systems and health coverage. The basket combines drugmakers with device manufacturers and a care insurer rather than concentrating on a single therapeutic pipeline. Recent strength in Lilly, Amgen, Medtronic and UnitedHealth supports entering now, although reimbursement pressure and clinical execution remain material risks. Launch basket (equal weight): MDT, LLY, UNH, AMGN, JNJ, ABT, DXCM Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.